Arcturus Therapeutics Director Edward Holmes Granted 15,000 Stock Options

This Form 4 filing reports that Edward W. Holmes, a director of Arcturus Therapeutics Holdings Inc. (ARCT), was granted 15,000 stock options on June 5, 2026. The options have an exercise price of $7.30 per share and expire on June 5, 2036. According to the footnotes, these options represent Holmes' 2026 annual grant as a member of the Board of Directors and will vest monthly over a one-year period from the grant date. Following this transaction, Holmes holds 15,000 stock options in total. The filing was signed by Ilan Katz as attorney-in-fact on June 15, 2026, and covers the reporting period ending June 5, 2026.